<p>Profile of semaglutide in the management of type 2 diabetes: design, development, and place in therapy</p>

Volume: Volume 13, Pages: 731 - 738
Published: Feb 1, 2019
Abstract
Type 2 diabetes mellitus (T2DM) has become one of the leading causes of morbidity and mortality in developed countries. Low efficacy, weight gain, and hypoglycemia are the main pitfalls of previous treatments for T2DM. New therapies have been designed with the aim of improving the results in efficacy and quality of life. Glucagon-like peptide 1 (GLP-1) receptor agonists (GLP-1 RA) increase glucose-dependent insulin secretion, decrease gastric...
Paper Details
Title
<p>Profile of semaglutide in the management of type 2 diabetes: design, development, and place in therapy</p>
Published Date
Feb 1, 2019
Volume
Volume 13
Pages
731 - 738
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.